TCM
PFE icon

Tang Capital Management’s Pfizer PFE Stock Holding History

Tang Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-53,039
Closed -$1.35M – 162
2025
Q3 		$1.35M Hold
53,039
– – 0.05% 148
2025
Q2 		$1.29M Sell
53,039
-13,761
-21% -$321K 0.07% 144
2025
Q1 		$1.69M Buy
66,800
+23,892
+56% +$625K 0.09% 131
2024
Q4 		$1.14M Buy
42,908
+17,170
+67% +$466K 0.08% 136
2024
Q3 		$745K Buy
+25,738
New +$751K 0.05% 130

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Tang Capital Management's PFE Position: Q4 2025 in Review

Tang Capital Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 53,039 shares — an estimated $1.35M sold.

Tang Capital Management first reported a position in PFE in Q3 2024 and held it in 5 quarters. The position peaked at $1.69M in Q1 2025. 2,915 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Tang Capital Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Tang Capital Management sold 53,039 Pfizer shares in Q4 2025, an estimated $1.35M.
  • Tang Capital Management first reported a position in Pfizer in Q3 2024 and held it in 5 quarters.
  • Tang Capital Management's Pfizer position peaked at $1.69M in Q1 2025.
  • 2,915 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Tang Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.